top of page
Lepirudin
來匹盧定
Mechanism of action:
Lepirudin 是一種直接凝血酶抑制劑(direct thrombin inhibitor),屬於重組水蛭素(recombinant hirudin)。Lepirudin 同時結合凝血酶(thrombin)的活性位點以及纖維蛋白原(fibrinogen)結合位點(exosite 1),形成高度穩定的複合體。隨後凝血酶無法將纖維蛋白原(fibrinogen)轉換為纖維蛋白(fibrin),降低凝血酶介導的凝血級聯反應與血栓形成。
Reference(s):
1. Smythe MA et al. (2005). A comparison of lepirudin and argatroban outcomes. Clin Appl Thromb Hemost.
2. Tardy B et al. (2006). Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood.
3. Lubenow N et al. (2005). Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. J Thromb Haemost.
bottom of page
